Y-mabs to participate at citi's 2024 global healthcare conference

New york, nov. 27, 2024 (globe newswire) -- y-mabs therapeutics, inc. (the “company” or “y-mabs”) (nasdaq: ymab), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer, today announced that it will participate in citi's 2024 global healthcare conference. members of the y-mabs management team will host one-on-one meetings at the conference on wednesday, december 4, 2024 in miami, fl.
YMAB Ratings Summary
YMAB Quant Ranking